
OSOZAP PLUS is a combination medicine containing Olanzapine and Fluoxetine, marketed by Kivonyx Healthcare Pvt. Ltd. It is prescribed for the management of depressive episodes associated with Bipolar I Disorder and treatment-resistant depression in appropriate patients. Olanzapine is an atypical antipsychotic, while Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). Together, these ingredients help manage certain mood-related symptoms under medical supervision. OSOZAP PLUS is available in tablet form with convenient 10 × 10 tablet packaging, supplied in blister strips inside a carton box. This neuropsychiatric formulation should be used strictly according to a qualified healthcare professional's prescription, with regular monitoring for potential side effects and treatment response.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.